PL1732898T3 - Pochodne tetrahydroizochinoliny i tetrahydrobenzazepiny jako inhibitory IGF-1R - Google Patents
Pochodne tetrahydroizochinoliny i tetrahydrobenzazepiny jako inhibitory IGF-1RInfo
- Publication number
- PL1732898T3 PL1732898T3 PL04719900T PL04719900T PL1732898T3 PL 1732898 T3 PL1732898 T3 PL 1732898T3 PL 04719900 T PL04719900 T PL 04719900T PL 04719900 T PL04719900 T PL 04719900T PL 1732898 T3 PL1732898 T3 PL 1732898T3
- Authority
- PL
- Poland
- Prior art keywords
- tetrahydroisoquinoline
- igf
- inhibitors
- tetrahydrobenzazepine derivatives
- tetrahydrobenzazepine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04719900A EP1732898B1 (en) | 2004-03-12 | 2004-03-12 | Tetrahydroisoquinoline- and tetrahydrobenzazepine derivatives as igf-1r inhibitors |
PCT/CH2004/000147 WO2005087743A1 (en) | 2004-03-12 | 2004-03-12 | Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as igf-1r inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1732898T3 true PL1732898T3 (pl) | 2008-06-30 |
Family
ID=34957074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL04719900T PL1732898T3 (pl) | 2004-03-12 | 2004-03-12 | Pochodne tetrahydroizochinoliny i tetrahydrobenzazepiny jako inhibitory IGF-1R |
Country Status (21)
Country | Link |
---|---|
US (1) | US7875631B2 (pl) |
EP (1) | EP1732898B1 (pl) |
JP (1) | JP2007528877A (pl) |
CN (1) | CN100590118C (pl) |
AR (1) | AR049323A1 (pl) |
AT (1) | ATE384700T1 (pl) |
AU (1) | AU2004317166B2 (pl) |
BR (1) | BRPI0418462A (pl) |
CA (1) | CA2555745C (pl) |
DE (1) | DE602004011578T2 (pl) |
DK (1) | DK1732898T3 (pl) |
EA (1) | EA200601687A1 (pl) |
ES (1) | ES2299825T3 (pl) |
IL (1) | IL177307A (pl) |
NO (1) | NO20063794L (pl) |
PL (1) | PL1732898T3 (pl) |
PT (1) | PT1732898E (pl) |
SI (1) | SI1732898T1 (pl) |
TW (1) | TW200530213A (pl) |
WO (1) | WO2005087743A1 (pl) |
ZA (1) | ZA200607198B (pl) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA200800786A1 (ru) * | 2005-09-09 | 2008-08-29 | Аналитикон С.А. | Тетрагидроизохинолиновые и тетрагидробензоазепиновые производные в качестве igf-1r ингибиторов, способ лечения или профилактики заболеваний, при которых благоприятна деактивация igf-1r, изделие для введения производных и хемотерапевтических агентов в комбинации, фармакологический инструмент для разработки и стандартизации тест-систем |
NZ566524A (en) * | 2005-09-09 | 2011-01-28 | Analytecon Sa | Isoquinolines as IGF-1R inhibitors |
WO2009073203A1 (en) | 2007-12-04 | 2009-06-11 | Amgen Inc. | Trp-m8 receptor ligands and their use in treatments |
EP2544672A1 (en) | 2010-03-09 | 2013-01-16 | OSI Pharmaceuticals, LLC | Combination anti-cancer therapy |
BR112013000254A2 (pt) * | 2010-07-05 | 2016-05-24 | Actelion Pharmaceuticals Ltd | derivados heterocíclicos 1-fenil-substituídos e seu uso como moduladores do receptor de prostaglandina d2 |
MX2013008833A (es) | 2011-02-02 | 2013-12-06 | Amgen Inc | Metodos y composiciones relacionadas con la inhibicion de receptor del factor de crecimiento similar a la insulina 1 (igf-1r). |
AU2012335541B2 (en) | 2011-11-11 | 2017-07-06 | Duke University | Combination drug therapy for the treatment of solid tumors |
CN104011021B (zh) | 2011-12-21 | 2016-08-24 | 埃科特莱茵药品有限公司 | 杂环衍生物及其作为前列腺素d2受体调节剂的用途 |
WO2014006585A1 (en) | 2012-07-05 | 2014-01-09 | Actelion Pharmaceuticals Ltd | 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
US8980259B2 (en) | 2012-07-20 | 2015-03-17 | Novartis Ag | Combination therapy |
CN104672136B (zh) * | 2013-11-30 | 2017-01-25 | 沈阳药科大学 | 1‑取代菲基‑n‑烷基(酰基)‑6,7‑二甲氧基‑1,2,3,4‑四氢异喹啉衍生物及其制备方法和用途 |
WO2017129763A1 (en) | 2016-01-28 | 2017-08-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of signet ring cell gastric cancer |
CN112500345B (zh) * | 2020-12-18 | 2022-06-21 | 西安石油大学 | α-氰基季碳取代四氢异喹啉化合物的合成方法 |
WO2024067463A1 (zh) * | 2022-09-27 | 2024-04-04 | 苏州阿尔脉生物科技有限公司 | 苯并[7]环烯类衍生物、包含其的药物组合物及其医药用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4349472A (en) | 1979-04-27 | 1982-09-14 | Schering Corporation | (S)-8(1-Adamantanecarbonyloxy)-7-chloro-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
CA1330560C (en) * | 1986-05-21 | 1994-07-05 | Maurits E. A. Vandewalle | Di- and tetrahydroisoquinoline derivatives |
WO1990002119A1 (en) * | 1988-08-18 | 1990-03-08 | Banyu Pharmaceutical Co., Ltd. | 1,2,3,4-tetrahydroisoquinoline derivatives |
US6337338B1 (en) * | 1998-12-15 | 2002-01-08 | Telik, Inc. | Heteroaryl-aryl ureas as IGF-1 receptor antagonists |
EP1113007A1 (en) * | 1999-12-24 | 2001-07-04 | Pfizer Inc. | Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
EP1341765A1 (en) * | 2000-12-07 | 2003-09-10 | AstraZeneca AB | Therapeutic compounds |
SE0102168D0 (sv) | 2001-06-19 | 2001-06-19 | Karolinska Innovations Ab | New use and new compounds |
SE0104140D0 (sv) | 2001-12-07 | 2001-12-07 | Astrazeneca Ab | Novel Compounds |
GB0212303D0 (en) | 2002-05-28 | 2002-07-10 | Isis Innovation | Molecular targetting of IGF-1 receptor |
-
2004
- 2004-03-12 JP JP2007502162A patent/JP2007528877A/ja active Pending
- 2004-03-12 AT AT04719900T patent/ATE384700T1/de active
- 2004-03-12 CN CN200480042030A patent/CN100590118C/zh not_active Expired - Fee Related
- 2004-03-12 EA EA200601687A patent/EA200601687A1/ru unknown
- 2004-03-12 US US10/591,174 patent/US7875631B2/en not_active Expired - Fee Related
- 2004-03-12 WO PCT/CH2004/000147 patent/WO2005087743A1/en active IP Right Grant
- 2004-03-12 EP EP04719900A patent/EP1732898B1/en not_active Expired - Lifetime
- 2004-03-12 SI SI200430684T patent/SI1732898T1/sl unknown
- 2004-03-12 DK DK04719900T patent/DK1732898T3/da active
- 2004-03-12 AU AU2004317166A patent/AU2004317166B2/en not_active Ceased
- 2004-03-12 PL PL04719900T patent/PL1732898T3/pl unknown
- 2004-03-12 DE DE602004011578T patent/DE602004011578T2/de not_active Expired - Lifetime
- 2004-03-12 ES ES04719900T patent/ES2299825T3/es not_active Expired - Lifetime
- 2004-03-12 BR BRPI0418462-9A patent/BRPI0418462A/pt not_active IP Right Cessation
- 2004-03-12 PT PT04719900T patent/PT1732898E/pt unknown
- 2004-03-12 CA CA2555745A patent/CA2555745C/en not_active Expired - Fee Related
-
2005
- 2005-02-25 TW TW094105813A patent/TW200530213A/zh unknown
- 2005-03-10 AR ARP050100920A patent/AR049323A1/es not_active Application Discontinuation
-
2006
- 2006-08-06 IL IL177307A patent/IL177307A/en not_active IP Right Cessation
- 2006-08-24 NO NO20063794A patent/NO20063794L/no not_active Application Discontinuation
- 2006-08-29 ZA ZA2006/07198A patent/ZA200607198B/en unknown
Also Published As
Publication number | Publication date |
---|---|
SI1732898T1 (sl) | 2008-06-30 |
ES2299825T3 (es) | 2008-06-01 |
WO2005087743A1 (en) | 2005-09-22 |
US7875631B2 (en) | 2011-01-25 |
AU2004317166A1 (en) | 2005-09-22 |
EP1732898A1 (en) | 2006-12-20 |
AU2004317166B2 (en) | 2010-11-11 |
DK1732898T3 (da) | 2008-05-13 |
ATE384700T1 (de) | 2008-02-15 |
PT1732898E (pt) | 2008-04-07 |
TW200530213A (en) | 2005-09-16 |
US20070129399A1 (en) | 2007-06-07 |
IL177307A0 (en) | 2006-12-10 |
NO20063794L (no) | 2006-12-12 |
DE602004011578D1 (de) | 2008-03-13 |
EA200601687A1 (ru) | 2007-04-27 |
CA2555745A1 (en) | 2005-09-22 |
CN100590118C (zh) | 2010-02-17 |
IL177307A (en) | 2011-09-27 |
AR049323A1 (es) | 2006-07-19 |
ZA200607198B (en) | 2008-04-30 |
CN1922147A (zh) | 2007-02-28 |
EP1732898B1 (en) | 2008-01-23 |
CA2555745C (en) | 2011-05-31 |
BRPI0418462A (pt) | 2007-06-05 |
JP2007528877A (ja) | 2007-10-18 |
DE602004011578T2 (de) | 2009-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL177307A0 (en) | Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as igf-1r inhibitors | |
ZA200700181B (en) | Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors | |
ZA200702394B (en) | Indozolone derivatives as 11b-HSD1 inhibitors | |
ZA200610771B (en) | Quinazolinedolone derivatives as PARP inhibitors | |
TWI370127B (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
PL1763517T3 (pl) | Pochodne pirymidyny jako inhibitory 11BETA-HSD1 | |
IL177278A0 (en) | Pyrazolotriazines as kinase inhibitors | |
IL179398A0 (en) | Dpp-ib inhibitors | |
IL185185A0 (en) | Azolylacylguanidines as ??-secretase inhibitors | |
EP1847532A4 (en) | IGF-1R Inhibitor | |
ZA200806148B (en) | 2-adamantylurea derivatives as selective 11ß-HSD1 inhibitors | |
HK1114380A1 (en) | Pyrrolopyrazoles as kinase inhibitors | |
IL179305A0 (en) | Dpp-iv inhibitors | |
EP1778693A4 (en) | AS KINASEINHIBITORS USEFUL COMPOUNDS OF TRICYCLIC HETEROARYL | |
IL183140A0 (en) | Substituted benzoquinolizine derivatives | |
IL189112A0 (en) | NOVEL HETEROCYCLIC NF-kB INHIBITORS | |
EP1968581A4 (en) | TETRACYCLIC KINASE INHIBITORS | |
HK1100002A1 (en) | 4-phenyl-pyrimidine-2-carbonitrile derivatives | |
IL182739A0 (en) | Acylatednonadepsipeptides used as lysobactin derivatives | |
SI1740574T1 (sl) | Derivati 4-amino-5-cianopirimidina | |
IL174845A0 (en) | Benzazepine derivatives as mao-b inhibitors | |
GB0421355D0 (en) | Inhibitors | |
ZA200702325B (en) | 2-acylaminothiazole derivatives | |
GB0421356D0 (en) | Inhibitors | |
ZA200706212B (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors |